Search Results 2351-2360 of 16198 for Epilepsy (Partial Onset)

1. Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face - Mayo Clinic

   During the early ... There are also less common very early (phase 0) and later (phase 4) phases. ... seizures, immunosuppression. Participating Mayo ...

2. Axicabtagene Ciloleucel Expanded Access Study - Mayo Clinic

   History or presence of primary CNS lymphoma and/or CNS disorder such as seizure disorder, cerebrovascular ischemia/hemorrhage, dementia, cerebellar disease, or ...

3. Smoking Cessation Prior to Surgery to Reduce Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes - Mayo Clinic

   This randomized phase III trial studies how well smoking cessation intervention works in reducing surgical complications in patients with newly diagnosed lung ...

4. A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) - Mayo Clinic

   paclitaxel alone in patients with biliary tract cancers (BTC) who have received one systemic therapy for advanced disease, as measured by Overall Response Rate ...

5. Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas - Mayo Clinic

   There are also less common very early (phase 0) and later (phase 4) phases. ... duration < 6 months) indolent/low grade B cell NHL: If patient has received ...

6. A Study of Deep Phenotyping in Patients With ALS - Mayo Clinic

   ... epilepsy. Dental fillings are permitted. Additional criteria for sites performing MRI cytography: Subjects who have a history of claustrophobia that cannot ...

7. Study to Evaluate the Safety and Effectiveness of BMS-986036 in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Cirrhosis - Mayo Clinic

   ... duration of treatment (BMS-986036 or placebo) plus 5 half-lives of study medication (5 days) plus 30 days (duration of ovulatory cycle) for a total of 35 ...

8. Publications - Hatem Amer, M.D. - Mayo Clinic

   Nonrecurrent Early Post-Transplantation Focal Segmental Glomerulosclerosis. Kidney Int Rep. 2020 Sep; 5 (9):1518-1525 Epub 2020 June 20. View PubMed; Sethi S ...

9. Publications - Phillip A. Low, M.D. - Mayo Clinic

   Clinical and Laboratory Features Predict Phenoconversion from Sporadic Adult-onset Ataxia to Multiple System Atrophy. Cerebellum. 2024 Dec 5; 24 (1):2 Epub ...

10. Left vs Left Randomized Clinical Trial - Mayo Clinic

    - A LVEF ≤ 50% within 6 months prior to enrollment. - Resting QRS duration ≥130 ms as evidenced by a historical 12-lead ECG prior to enrollment OR ...